Aivot Capital Fund
AIVOT AI is a technology-driven innovation company built on a mission to make Artificial Intelligence meaningful, practical, and accessible for organizations across the world. Established in 2020, the company began with a simple belief—that AI should not remain confined to research labs or large enterprises but should serve as a real-world solution for challenges in healthcare, agriculture, sustainability, public systems, and everyday business operations. Over the years, AIVOT AI has grown into a global player, delivering projects across the USA, EU, and emerging markets while steadily expanding its in-house capabilities and product portfolio. The company’s solutions—including iTerve, BLY, SoilTech, AISUP, and several new innovations—reflect deep technical expertise supported by extensive research, mass data collection, and global collaborations. Its rapid progression is strengthened by partnerships with organizations such as Vita Madagascar, Apollo TeleHealth, USV, and various Caribbean governments, enabling wide-scale deployment of AI-powered health and vital-scanning technologies. AIVOT AI’s leadership and advisory board bring decades of experience in cryptology, finance, clinical sciences, compliance, technology, and global business. The company’s recognition through awards such as the Internet 2.0 Outstanding Organization Award and the Rashtriya Udyog Ratan highlights its commitment to excellence. With its AIF license in GIFT City, AIVOT AI has extended its capabilities into fund management, reinforcing its vision of integrating advanced AI with long-term value creation for investors and industries alike.
